USSU, CPRK, NXPC, XSNX, QMCI
ZVUE, GOFH, SOIS, GRMU, GSPG, CPWM, HEPH, MYEC
Our Stocks to Watch today include USA Superior Energy Holdings Inc. (OTCBB: USSU), Copper King Mining Corp. (OTC: CPRK), NeXplore Corp. (OTC: NXPC), XsunX Inc. (OTCBB: XSNX), QuoteMedia Inc. (OTCBB: QMCI), ZVUE Corp. (NASD: ZVUE), GoFish Corp. (OTCBB: GOFH), Striker Oil & Gas Inc. (OTCBB: SOIS), GREM USA Inc. (OTC BB: GRMU), GoldSpring Inc. (OTCBB: GSPG), Cost Plus Inc. (NASD: CPWM), Hollis-Eden Pharmaceuticals Inc. (NASD: HEPH) and MyECheck Inc. (OTCBB: MYEC).
USA SUPERIOR ENERGY (OTCBB: USSU)
"Up 15.85% in morning trading"
USA Superior Energy Holdings, Inc., a development stage company, operates in the energy industry in the United States. The company, through its wholly owned subsidiary, USA Superior Energy, Inc., engages in the development, ownership, and operation of prospects and energy projects in East and Southeast Texas. It also focuses on using nitrogen technology to recharge and produce oil and gas from under-pressured partially depleted reservoirs. The company was founded in 2005 and is based in Houston, Texas.
June 6 - USA Superior Announces $87 Million Net Present Value of Probable and Proven Reserves in Bateman Field
USA Superior Energy Holdings, Inc. (OTCBB: USSU), a Houston based energy company ("Company") focused on shallow well enhanced oil recovery (EOR) and drilling of existing proven fields that have been idle or marginally producing, announced the completion of its probable reserve studies for its Bateman and Benton Fields. Mr. Rowland Carey, Chairman and CEO, announced, "We have now completed our lengthy analysis of our probable and proven recoverable reserves. The total net present value of our holdings in the Bateman project, when fully developed, is approximately $87 million (standard industry discount rate of 10% with an $100 average price of oil)."
Mr. Rowland Carey, stated, "I am pleased to announce the completion of our Probable and Proven Reserve forecasting and budget project. The net present value of the Probable and Proven Reserves for the Bateman Project is $87 million. We have less than 60 million shares outstanding and certainly believe that the market has not had the necessary information to properly value the Company. We are excited to communicate to the market the results of these studies as the reason for our belief that the Company is dramatically undervalued."
Mr. Carey further stated, "Our management team is proud of where we have brought the Company to this point. Our growth will require us to add additional members to the management team with appropriate expertise and to expand our Board of Directors. Our probable and proven reserve model assumes that we gain the continued access to the capital that is essential to grow, including the capital planned for this quarter of up to $2.0 million. This capital will enable us to maintain our business plan's operational pace and the 2008 production budget targets announced yesterday."
The Bateman project will be the focus of the company's activity in 2008 and 2009. This field's production will be accelerated during 2008. The net production (after payment of royalties) during the ten year life is approximately 1.5 million barrels of oil in the Bateman field. This would total approximately $146 million of net revenue (after royalties).
Mr. Carey additionally stated: "Under USA's current field development program, we intend to re-invest 75% of the cash flow for capital expenditures into field development. The oil production from field development planned in the second half of 2008 permits our margins to increase significantly in 2009 and beyond. This has a substantial impact on our cash flow, with cash flow exceeding our total expenditures substantially during 2009 on our current budget pace. We anticipate utilizing this internal cash flow for other field or acreage acquisition and enhanced recovery opportunities as well as consider joint ventures and investments."
Mr Witte, Vice President of geology, stated: "I think now is an appropriate time to broaden the market's understanding of our holdings. In completing the analysis of the Bateman Field we have identified numerous proven and probable development opportunities. Thirty-six infill-drilling locations have been identified. We are currently in review with our third party reservoir engineer, Cathedral Resources, that does independent proven reserve study updates for SEC purposes, where we are categorizing each infill location."
Cathedral's end of year 2007 reserve report has identified proven reserves of 445,000 net BO with an undiscounted value of $18.9 million and a NPV10% of $3.8 million. A breakdown of the reserves shows PDP reserves of 194,300 net BO with a NPV 10% of $1.9 million from existing wells, and twenty PUD locations with 250,650 net BO with a non-discounted NPV of $11 million and a discounted NPV10% of $1.93 million.
The Company believes that upon continuing execution of our plan of development (wellbore and reservoir enhancement), oil reserves that normally would have been produced far in the future will now be produced within the next 10 to 20 years. In our probable and proven reserve model, we utilize the SEC required guidelines, historic production rates and existing production conditions to determine the NPV. The average PUD has a total operating expense of $311,000 per well over the 75-year expected well life. Reducing the production life of these wells from 75+ years to 10 or 20 years will reduce total operating expenses from $311,000 per well to $61,000 per well over the wells' life. This reduction of expenses and accelerated oil production rate will significantly increase the NPV discount rate of 10% on the PUD identified.
The Company's combinations of technologies -- cased hole horizontal stimulation to increase the connectivity between the oil bearing rocks and the wellbore, and nitrogen generators to repressurize the large amounts of oil left in the ground -- is a business model that produces larger increases of oil out of older proven fields at lower cost. Having 6 to 9 months of accelerating production rates will allow the Company to establish a new proven historic production rate, thereby allowing the Company to continue to prove up the viability of these well bore and reservoir enhancement technologies. Much of the oil the Company has in a probable reserve category can then be revised to a proven category for SEC reporting purposes.
In addition to developing the existing proven reservoirs, USA has identified an exploratory potential growth opportunity 600 feet under its Bateman acreage. USA believes it can successfully isolate and exploit an opportunity identified in the Edwards formation using modern completion practices. Early in the discovery and development phase of the field, four wells were drilled in 1982 into the top of the Edwards formation. All wells showed a formation with good porosity and permeability. Results of the fifth well drilled in 1983 on the Company's acreage showed eleven feet of oil sitting on top of water from conventional whole core. The Company controls over 200 acres of this Edwards oil potential in a structural position above the oil-water contact. The Company plans to test this formation later this year by entering one or more of the older wells. While very exciting and of potential value, none of these potential large recoveries are calculated in our probable reserve model.
For more information, visit www.usa-superior.com.
COPPER KING MINING (OTC: CPRK)
Copper King Mining Corporation currently owns approximately 1200 acres in the Drum Mountains of Utah, which are patent deeded mining claims which contain gold, silver and copper. The company recently added to its holdings by filing six more claims on land which was inside their holdings, but not patent deeded. Contiguous to that acreage is approximately 1100 acres of claims filed by Western Utah Copper Company. As the companies explored the concept of a joint venture on the Drum Mountain properties, it was decided that a very viable consideration was to join the total assets of both companies.
June 3 -
Copper King Mining Corporation Announces Commitment for Long-Term Financing
OCS Capital Group, LLC Delivers Permanent Financing Commitment Letter
Copper King Mining Corporation (OTC: CPRK), an ore mining, processing, and exploration company located in Milford, Southern Utah, announced that it has obtained a long-term financing commitment for the company’s copper mining and milling operations from OCS Capital Group LLC (OCS).
The OCS financing commitment represents a firm $100,000,000 project funding commitment. The funding is drawn against federal revenue bonds. The bonds, when issued, will be purchased by OCS’s investment banking house. The parties expect it to take up to 4 months to complete the entire funding. OCS is currently negotiating to assist in providing a bridge loan for the company for ongoing operational needs.
OCS, an OCS American Limited Liability Company, is an international bond-law consulting firm with offices in Pennsylvania, Washington DC, and Albuquerque, NM. It is also a consultant on government relations and government affairs. It provides technical and professional services to local, municipal, state and federal government agencies in the United States and South America.
OCS past projects have ranged from $25 Million, up to $8.3 Billion and vary from mining to commercial developments in cities and towns. Additional information will be released as approved by the lender.
NEXPLORE CORPORATION (OTC: NXPC)
NeXplore Technologies is developing a Web 2.0 search engine and an assortment of social networking portals and tools that will enable users to personalize their Web experience and tailor it to their unique needs, interests, and online pursuits. The Company’s social computing platform, MyCircle.com, offers an enhanced, user-friendly graphical interface search engine, combined with innovative backend technology, which enables users to improve the way they connect with information and other people on the Worldwide Web. MyCircle’s Web 2.0 interface provides users with an online tool for sharing their Blogs, Voice-Over IP, photos and documents, podcasts and videocasts, classified advertising, instant messages, SMS text messages, Chat and personal profiles.
June 5 - NeXplore Corporation Transitions Newly Acquired ClickCaster.com to NeXplore Grid Server
NeXplore Leverages Grid Layer From Layered Technologies for Fast Integration, Speedy Launch, Instant Scalability
NeXplore Corporation (OTC: NXPC) announced the successful transitioning of the recently acquired ClickCaster.com website to the NeXplore Grid Server. Powered by The Grid Layer hosting solution from Layered Technologies, in combination with 3Tera Inc.'s virtualization software AppLogic, the NeXplore Grid Server is the company's virtual private data center for efficiently and cost-effectively operating and managing NeXplore's growing portfolio of Web 2.0 products and destinations.
The rapid transitioning to the NeXplore Grid Server of ClickCaster.com enables NeXplore to quickly monetize and scale this popular website that provides tools for fast-and-easy audio and video podcast creation, publishing and management. Upon acquisition by NeXplore, ClickCaster.com had approximately 245,000 unique users, a number NeXplore plans to significantly grow by the end of 2008.
NeXplore currently utilizes the NeXplore Grid Server to host and manage NeXplore Search, the company's recently launched Web 2.0 search engine optimized for a superior end-user experience, rich-media display and social network integration. NeXplore is working to integrate ClickCaster.com podcasting capability into NeXplore Search.
"The quickness, low cost and relative ease with which we were able to transition ClickCaster.com to the NeXplore Grid Server validates our decision to utilize this cutting edge hosting and application management system," said Dion Hinchcliffe, chief technology officer for NeXplore Corporation. "The pace of innovation today is blistering. Web companies hobbled by the cost and complexity associated with traditional infrastructure — datacenter co-location, private racks and managed hosting services, etc. — are destined for extinction. The road to success in today's dynamic Web 2.0 world — the path that NeXplore is forging — is paved with glitch-free performance, speed-to-market and instant, on-demand scalability."
XSUNX INCORPORATED (OTCBB: XSNX)
Xsunx, Inc., a thin-film photovoltaic (TFPV) company, focuses on developing thin film photovoltaic (TFPV) amorphous silicon solar cell manufacturing processes to produce TFPV solar modules. Its product includes XsunX ASI-120 module, which is a 125 peak watt TFPV solar module utilizing glass substrates and a proprietary semiconductor manufacturing system. XsunX ASI-120 provides for a module delivering high power output, and size and framing that would allow for the use of various existing mounting systems. The target markets for the TFPV solar module include solar farms, government agencies, and utility companies, as well as power purchase agreements and large commercial installations worldwide. The company, formerly known as Sun River Mining, Inc., was incorporated in 1997 and changed its name to XsunX, Inc. in 2003. XsunX is headquartered in Aliso Viejo, California.
June 6 -
XsunX Inc. Included in Sector Close-Up on Renewable Energy Stocks
www.RenewableEnergyStocks.com, a leading investor news and research portal for the renewable energy sector within Investorideas.com, presents a sector close-up on renewable energy stocks and some of the Indices tracking the sector.
Among this week’s featured issues is XsunX, Inc. (OTCBB: XSNX). Based in Aliso Viejo, Calif., XsunX is developing amorphous silicon thin film photovoltaic (TFPV) solar cell manufacturing processes to produce TFPV solar modules. To deliver its products, the Company has begun to build a multi-megawatt TFPV solar module production facility in the United States to meet the growing demand for solar cell products used in large scale commercial projects, utility power fields, and other on-grid applications. Employing a phased roll out of production capacity, it plans to grow manufacturing capacities to over 100 megawatts by 2010.
"We are extremely pleased to have XsunX selected to be listed on the Ludlow Energy Ventures renewable energy index, which as a reputable index, attracts long term investors with a buoyant viewpoint on alternative energy," said Tom Djokovich, CEO of XsunX, Inc.
The Ludlow Small Cap Energy Index is a basket of small cap alternative energy stocks.
More info on XsunX, Inc. can be found at www.xsunx.com or www.investorideas.com/co/xsnx/default.asp.
INC. (OTCBB: QMCI)
Inc. is a leading software developer
and provider of real-time streaming financial market
information, decision-support, news and research solutions
to brokerage, financial services companies, business
and media corporations. Among its many leading-edge
products lines, the Company offers data feeds, news,
dynamic market content solutions, interactive stock
research tools, financial applications and real-time
wireless applications. QuoteMedia provides data and
services for companies such as the NASDAQ, the OTCBB,
Dow Jones & Company, Forbes.com, Scotia Capital,
Business Wire, Southwest Securities, Regal Securities,
FBR Direct, Broadridge Financial Solutions, Inc.,
AIM Trimark, Zacks Investment Research, ChoiceTrade,
QTrade, Schaeffer's Investment Research, Automated
Financial Systems, WallStreet*E, and others. For more
information, visit www.quotemedia.com.
June 6 - QuoteMedia to Exhibit at SIFMA Technology Management Conference in New York, June 10 - 12
QuoteMedia, Inc. (OTCBB: QMCI), a leading provider of market data, corporate research information and financial applications, announced that it is scheduled to participate as an exhibitor at the Securities Industry and Financial Markets Association’s Technology Management Conference and Exhibit in New York, taking place on June 10th through 12, 2008.
SIFMA's 28th Annual Technology Management Conference & Exhibit is the industry's leading event with over 300 vendors and 7,000 attendees, and it will allow QuoteMedia to present its products and services to the senior executives responsible for managing communications, data processing, market data, information security, trading room support, web and Internet technology, information systems and other related technology activities.
In particular, QuoteMedia will be demonstrating its newly launched QuotestreamTM Professional streaming portfolio management system, together with its QuotestreamTM Wireless companion product, designed for use by financial services professionals. QuotestreamTM Professional offers unparalleled functionality at extremely aggressive pricing at a time when cost reduction, with no reduction in capabilities, is a paramount concern across the industry.
QuoteMedia will also be showcasing QuotestreamTM II for enterprise level deployments to retail customers. QuotestreamTM II is geared towards providing a professional level experience to non-professional users.
Additionally, QuoteMedia will be available to meet with potential clients regarding comprehensive content solutions for intranet and public facing websites and media/web portals.
Finally, sales and technical staff will be on hand to discuss QuoteMedia’s broad range of DataFeed solutions for companies looking to power their applications and systems with ultra-low latency streaming quote data and supplementary feeds, or those wishing to replace existing legacy solutions with state-of-the-art data services, while benefiting from significant cost savings.
Paul Pryde, QuoteMedia’s Senior Vice President & Regional Director, together with New York Corporate Sales Director George Katsch, and Chief Technology Officer Christian Amott, will be present to meet attendees at Booth #1608.
The conference will take place at the Hilton New York, 1335 Avenue of the Americas, NYC. For more information on the event, visit http://events.sifma.org/2008/107/event.aspx?id=526.
ZVUE CORPORATION (NASD: ZVUE)
"Up 29.00% in morning trading"
ZVUE Corporation, a digital entertainment company, provides user-generated video online. It network of content Web sites comprise eBaumsWorld.com, Putfile.com, Holylemon.com, UnOriginal.co.uk, YourDailyMedia.com, Dorks.com, FunMansion.com, and ZVUE.com, which offer media files, including music videos, news clips, television shows, short films, and feature-length films, as well as rights to additional media files in various genres, including teens, children, and independent films. The company also provides games, jokes, and photos. As of November 1, 2007, it entertained approximately 24 million visitors per month through its network of Web sites. In addition, ZVUE Corporation offers personal media players in mass-market under ZVUE brand to purchase online and in approximately 2,200 Wal-Mart stores. The company was formerly known as Handheld Entertainment, Inc. and changed its name to ZVUE Corporation in November 2007. ZVUE is headquartered in San Francisco, California.
June 9 -
ZVUE Announces 50,000 Unit Order for Three New Media Players
Company Receives Orders for Three New Devices With a Sales Value of Approximately $1.75M Each to Be in Nationwide Retail Distribution in Q3
ZVUE Corporation (NASD: ZVUE), a global digital entertainment company, announced that it has received orders for three new media players, each from a major national mass market retailer. The players represent the next in a series of planned product offerings that the company intends to bring to the market in 2008 as a part of its strategy to deliver value-based handheld media players that feature the latest in product design and are pre-packaged with compelling themed digital content from leading content providers. The company introduced this strategy earlier this year with the successful launch of its ZVUE Spirit personal media player.
Similar to the Spirit, each of the new players will be tied to a specific theme or promotion. Two of the new players are MP3 video players featuring a 2.4 inch screen, an FM tuner, photo slide show, voice recorder and expandable micro SD card slot. The third offering is a MP3 player which will feature 1 GB of memory with a voice recorder and built-in speaker. The company has received orders for approximately 50,000 units with a total value of approximately $1.75million. The company expects to deliver the players in third quarter of 2008. With these orders, ZVUE will have already received firm orders for nearly 100% of last years total unit volume and nearly 60% of 2007 sales with even more projects under development.
“The ZVUE products team continues to execute successfully its strategy to ‘source, enhance and sell’ ZVUE’s unique and targeted pre-loaded product offerings,” said Jeff Oscodar, president and CEO of ZVUE Corporation. “I’m thrilled that for the second time in three months we have received orders that will put new ZVUE products into mass market retail distribution.”
GOFISH CORPORATION (OTCBB: GOFH)
"Up 23.33% in morning trading"
GoFish Corporation (www.gofishcorp.com), headquartered in San Francisco with offices in Los Angeles and New York, is a leading entertainment and media company, with a focus on reaching kids, teens and moms, and specializing in aggregating, and distributing premium content on a large network of quality sites for which GoFish is the exclusive brand advertising monetization partner. The GoFish Network of sites reaches nearly 21 million unduplicated online users domestically, and over 66 million worldwide. GoFish has been a pioneer in online content appealing to the hard-to-reach youth market and their parents. It presently ranks as the 3rd largest kids/teens opportunity and a top 5 ‘mom’ opportunity for blue-chip advertisers.
June 6 -
GoFish Corporation Names Tribal DDB Worldwide Founder and CEO Matt Freeman as Chief Executive Officer, Board Director
Move Extends GoFish Leadership in Creation of Digital Brand Immersion Network for Major Advertisers
GoFish Corporation (OTCBB: GOFH), a leading online media company with nearly 21 million unique users a month domestically and 66 million a month worldwide, named Matt Freeman, former Founder and Chief Executive Officer of Tribal DDB Worldwide, as Chief Executive Officer and a member of the Company’s Board of Directors. He succeeds Michael Downing who will leave the company.
“Companies like McDonald’s and Nike cannot build their brands through buying search keywords alone,” says Mr. Freeman. “As online audiences continue to fragment beyond the portals, major brands still need a way to connect with mass audiences. GoFish offers advertisers meaningful brand engagement, not merely direct response, across an ever-expanding portfolio of digital properties that are at the vanguard of consumers’ passions and interests.”
“Matt is a seminal figure in the digital marketing and advertising industry. He is an experienced, entrepreneurial chief executive with a proven track record of building businesses in highly competitive domestic and international markets. His broad-based experience includes running industry leading companies from their earliest stages to mature market leadership and delivering exceptionally high levels of revenues and profit,” says Tabreez Verjee, President of GoFish. “We are excited to have him take day to day responsibility for GoFish as we expand our well positioned vertical advertising business and establish ourselves as a digital entertainment media company.”
Mr. Freeman adds, “Since its successful launch this past February, the immersive experience that GoFish Network uniquely offers has allowed it to grow to nearly 21 million unique users domestically and 66 million unique users worldwide, becoming one of the ‘Big 3’ youth brands on the Internet. Even more exciting to me is GoFish’s proven ability to expand its ‘Brand Immersion’ approach in advertising to Young Adults and Moms demos, underscoring the company’s huge potential to provide brand advertisers a premium environment with a highly-engaged audience no matter who the target. This is a company with an exceptionally promising future.”
Mr. Freeman helped found Tribal DDB Worldwide in 1998 growing the company from 45 employees and $5 million in annual revenue to over 1,500 employees and $250 million in annual revenue while building a global network of 45 offices spanning 28 countries. He developed broad, global relationships with Fortune 100 clients including PepsiCo, Philips, Johnson & Johnson, McDonald’s, Volkswagen, ExxonMobil and Unilever. Mr. Freeman also started and scaled specialized business units in Search (SEM & SEO), Hosting, Database development & Analytics (including proprietary econometric modeling applications), Digital Healthcare Marketing, Gaming, Mobile, iTV and Strategic Consulting.
In January 2006, AdWeek named Tribal DDB Worldwide its Interactive Agency of the Year and in January 2008, Adverting Age awarded it Global Agency Network of the Year. Both publications cited Mr. Freeman’s leadership as a critical factor in Tribal’s enduring success.
In 1997 and 1998, Mr. Freeman was Executive Creative Director Modem Media / Poppe Tyson (since then acquired by Digitas, Inc.; now a Division of Publicis Group). There, he led efforts on IBM & other key clients and was part of the merger integration team with Modem Media and Poppe Tyson. Before that, he was Partner, Executive Creative Director at Poppe Tyson (formerly a division of True North, now Interpublic Group from 1995 to 1997. Earlier in his career, Mr. Freeman was a writer at MTV working on Beavis & Butthead and MTV Beach House and he was a private school English teacher.
Mr. Freeman, a graduate of Dartmouth College and the NY School of Visual Arts, has been inducted into the American Advertising Federation Hall of Achievement; is the Founder of the Interactive Agency Board of the IAB, is an active Board member of the Advertising Club and the American Association of Advertising Agencies (4As) and is a member of the Marketing Advisory Board of the Modern Museum of Art (MOMA).
STRIKER OIL & GAS (OTCBB: SOIS)
"Up 10.77% in morning trading"
Striker Oil & Gas, Inc. engages in the exploration, acquisition, development, production, and sale of natural gas, crude oil, and natural gas liquids primarily from conventional reservoirs in the United States. It operates onshore along the Gulf Coast of Texas and Louisiana, as well as East Texas and Mississippi. The company holds interests in the Abbeville field and the West Abbeville prospect located in Vermillion Parish, North Edna field and Welsh Field located in Jefferson Davis Parish, and South Creole Prospect located in Cameron Parish in Louisiana; North Cayuga Prospect in Henderson County and Catfish Creek Prospect in Henderson and Anderson Counties in Texas; and North Sand Hill Field located in Greene County, Mississippi. Striker Oil & Gas is based in Houston, Texas.
June 9 -
Striker Oil & Gas to Drill Three Additional Wells on Its Catfish Creek Prospect
Striker Oil & Gas, Inc. (OTCBB: SOIS) announced that it has entered into a three well drilling program on its Catfish Creek Prospect located in East Texas. The first well should spud within the next 60 days with the additional wells to follow. These wells are expected to be drilled and completed during the 3rd fiscal quarter of 2008 testing the Pettit and Rodessa formations which are found in our initial two successful wells. Based on the initial wells, these three wells, if successful, should average approximately 125,000 gross barrels of oil reserves per well which equates to a combined estimate of $51,000,000 in future gross revenue at today’s crude oil prices to the 100% working interest.
This prospect consists of over 8,000 gross acres with depths earned to 100 feet below the base of the Pettit formation. Full development of this prospect could result in 20 to 40 wells. Striker has approximately 33% working interest before payout (25% after payout) on this prospect.
“We are happy to begin this next phase of development on our largest prospect,” said Kevan Casey, Chief Executive Officer of Striker. “The Catfish Creek prospect should be one of the biggest contributors to growing our reserves and production for 2008.”
GREM USA (OTCBB: GRMU)
"Up 61.11% in morning trading"
GREM USA, Inc., a development stage company, engages in the design and manufacture of custom handmade and mass-produced electronic guitars, amplifiers, and accessories. The company was formerly known as Global Business Markets, Inc. and changed its name to GREM USA, Inc. in December, 2004.The company was incorporated in 1999 and is based in Fort Wayne, Indiana.
June 6 -
GREM USA Commences Introductory Merger Talks With Top-Tier Guitar Manufacturer
GREM USA (OTC BB: GRMU) ("GREM" or "the Company"), an emerging leader in the design and manufacturing of custom hand-crafted and electric guitars, announced that the Company has commenced introductory merger talks with a nationally-recognized top-tier guitar manufacturer ("the Manufacturer").
The Manufacturer, who will be disclosed at a later date upon formal agreement of a letter of intent, is widely recognized as a leading producer of guitars throughout the United States and worldwide. The Manufacturer has existing profitable revenues in the tens of millions of dollars, complete and audited financial statements, and is believed to meet the requirements for listing on NASDAQ National Market.
The purpose of the merger would be to afford the Manufacturer the acquisition of a complementary business vehicle to which it may use to access public markets and expand its shareholder base. The benefits of undertaking this transaction with GREM specifically include its existing fully reporting status, its Fort Wayne, Indiana production facility (which could produce significantly more yield with the assistance of the Manufacturer), significant tax advantages to the Manufacturer, and the strong brand recognition of GREM guitars in the high-end market. GREM would intend to continue producing guitars in Fort Wayne, Indiana and would inherit thousands of additional distribution channels for its custom guitars. It is anticipated that the Manufacturer would absorb GREM liabilities as part of the merger terms. Although GREM is envisioned to be the surviving entity, current GREM officers and directors would be replaced by officers and directors of the Manufacturer, resulting in a complete change of control of the Company.
The Company wishes to emphasize that the process is in its initial stages and may take many months to complete, if at all. Considering such, management believes the impact of the proposed transaction to be extremely beneficial to common shareholders. A completed agreement would offer the opportunity for our shareholders to become a part of a mature, profitable company expected to be listed on a major national exchange. Although a share consolidation would be necessary, it is the belief of GREM management that the Manufacturer possesses strong fundamentals and would have little difficulty attracting investment interest into the new entity and maintaining a market capitalization necessary for continued listing on the NASDAQ.
President of GREM USA, Edward Miers, commented, "We're excited about the beginning of this process, and believe it could be a historic transaction in the US markets. Everyway we've looked at this, it makes a lot of sense. Given our current market capitalization of fewer than 500 thousand dollars, we think the merger process with a Manufacturer of this magnitude would add substantial value to our shareholders. If we are able to consummate this process, it would effectively result in GREM shareholders, who may have acquired our shares while we were valued at a couple hundred thousand dollars, a million dollars, or even several million dollars, to own a near-proportionate interest in a Manufacturer that could easily be expected to garner capitalizations exponentially higher than levels GREM has ever achieved. We believe this transaction would result in all shareholders experiencing a considerable appreciation in the value of their holdings, and that's why we're going to work diligently to make this transaction a reality."
Although GREM management believes this proposed merger is achievable, investors are cautioned that there is no guarantee that the described merger will take place, and are also apprised that it would further require a legal and regulatory process of an indeterminate timeframe. GREM will release announcements regarding the proposed merger as they become available.
GOLDSPRING INCORPORATED (OTCBB: GSPG)
"Up 54.59% in morning trading"
GoldSpring, Inc. is a North American precious metals mining company, focused in Nevada, with extensive, contiguous property in the Comstock Lode District. Our Company was formed in mid-2003, and we acquired two properties in the Comstock Lode before the end of the year. We secured permits, built an infrastructure and brought the exploration project into test mining production within a year of its acquisition. The Company, in 2005, began consolidating the Comstock Lode by acquiring additional properties in the district, expanding our footprint and creating opportunities for exploration and mining. We are an emerging company, looking to build on our success through the acquisition of other mineral properties in the Comstock Lode District with reserves or exploration potential. The Company's objectives are to increase reserves through exploration, expand its footprint in the Comstock, resume mining, optimize its production and maximize shareholder value.
June 6 -
GoldSpring to Provide Special Investor Update on Tuesday, June 10th to Discuss Significant Developments and Preliminary Findings of 43-101 Resource Report on Valuation of Company's Mineral Holdings in Nevada's Comstock Lode Mining District
Company To Hold Conference Call and Webcast at 11 a.m. Eastern Time that Day
GoldSpring, Inc. (OTCBB: GSPG), the largest mineral rights land position in Nevada's Comstock Lode Mining District, announced that it will hold a conference call on Tuesday, June 10th at 11 a.m. eastern time at which time it expects to discuss the preliminary findings of the 43-101 resource report that was conducted by an independent geology firm to determine the value of the mineral rights held by the Company in Nevada's Comstock Lode Mining District.
For the conference call, interested participants should dial 866-214-7077 when calling within the United States or 416-915-9608 when calling internationally along with pass code 8254829. There will be a playback available as well. To listen to the playback, please call 888-203-1112 when calling within the United States or 719-457-0820 when calling internationally. Please use pass code 8254829 for the replay.
The call is also being webcast and can be access at GoldSpring's website at www.goldspring.us.
Pursuant to Regulation FD, the company reports that drill hole #40, which is not included in the preliminary resource report being discussed on Tuesday, encountered 5 feet of ore containing 1.937 ounces of gold per ton. This is the highest grade of ore since the commencement of the drilling program in December 2007.
COST PLUS INCORPORATED (NASD: CPWM)
"Up 21.31% in morning trading"
Cost Plus, Inc., along with its subsidiaries, operates as a specialty retailer of casual home furnishings and entertaining products in the United States. It offers home decorating items, such as furniture, rugs, pillows, bath linens, lamps, window coverings, frames, and baskets; and furniture products, including ready-to-assemble living and dining room pieces, handcrafted case goods, and occasional pieces. The company also provides kitchen items, including glassware, ceramics, textiles, and cooking utensils; and kitchen products comprising baking, food preparation, barbecue, and dining. In addition, it provides jewelry, fashion accessories, and personal care items, as well as gift and decorative accessories, including collectibles, candles, framed art, and holiday and seasonal items. Further, the company offers gourmet foods and beverages, including wine, microbrewed and imported beer, coffee, tea, and bottled water. As of December 31, 2007, it operated 298 stores under World Market, Cost Plus World Market, Cost Plus Imports, and World Market Stores names in 34 states. The company was founded in 1946 and is headquartered in Oakland, California.
June 9 -
Cost Plus Comments on Pier 1 Proposal
Cost Plus, Inc. (NASD: CPWM) confirmed that it received a non-binding, highly conditional proposal from Pier 1 Imports, Inc. (NYSE: PIR) to acquire 100% of the outstanding shares of Cost Plus in a stock-for-stock transaction.
The Cost Plus Board of Directors, consistent with its fiduciary duties and in consultation with its financial and legal advisors, will meet in due course to review and discuss Pier 1’s unsolicited proposal. The Company noted that Cost Plus shareholders do not need to take any action with regards to this proposal.
Peter J. Solomon Company is acting as financial advisor to Cost Plus and Skadden, Arps, Slate, Meagher & Flom LLP and Wilson, Sonsini, Goodrich & Rosati LLP are acting as legal advisors.
HOLLIS-EDEN PHARMACEUTICALS INCORPORATED (NASD: HEPH)
"Up 9.28% in morning trading"
Hollis-Eden Pharmaceuticals, Inc. engages in the development of a proprietary class of adrenal steroid hormones as novel pharmaceuticals for human health. The company, through its Hormonal Signaling Technology Platform, is developing a new series of small molecule compounds that are metabolites or synthetic analogs of endogenous hormones derived by the adrenal glands from the body's most abundant circulating adrenal steroid. These steroid hormones are designed to restore the biological activity of cellular signaling pathways disrupted by disease and aging, which regulate innate and adaptive immunity, reduce nonproductive inflammation, and stimulate cell proliferation. Its clinical drug development candidates include TRIOLEX (HE3286), a next-generation compound currently in clinical trials for the treatment of type 2 diabetes, ulcerative colitis, and being prepared for clinical trials in rheumatoid arthritis; and APOPTONE (HE3235), a next-generation compound being prepared for clinical trials in cancer. In addition, Hollis-Eden has an active research program that is generating additional new clinical leads that are being evaluated in preclinical models of various diseases. The company was founded in 1992 and is headquartered in San Diego, California.
June 9 -
Hollis-Eden Pharmaceuticals Reports Additional Positive Data from Phase I/II Clinical Trial with TRIOLEX™ Supporting Anti-Inflammatory Approach to Treating Type 2 Diabetes
Data to date demonstrate that TRIOLEX is safe and well tolerated, and improves insulin sensitivity and lowers fasting glucose levels in obese insulin resistant subjects
Hollis-Eden Pharmaceuticals, Inc. (NASD: HEPH) announced additional positive interim data from its on-going Phase I/II clinical trial with its investigational oral drug candidate TRIOLEX (HE3286), supporting the potential benefit of a novel anti-inflammatory approach to improving insulin sensitivity in patients with type 2 diabetes. The additional data extend previously reported data from this study and demonstrate that TRIOLEX is safe and well tolerated to date, and that it significantly improved insulin sensitivity and significantly lowered fasting blood glucose, insulin and triglyceride levels in obese insulin resistant subjects treated orally with the compound for 28 days when compared to placebo-treated subjects.
In addition, all subjects had elevated levels of MCP-1, a chemokine identified in the scientific literature to be associated with the cause of insulin resistance, before initiating TRIOLEX therapy, and showed a significant drop in MCP-1 in serum and IL-6 in peripheral blood mononuclear cells when treated with the compound at the highest dose, compared to placebo-treated subjects. This finding is consistent with the anti-inflammatory mechanism of action of TRIOLEX. The primary clinical investigator, Sherwyn Schwartz, M.D., CEO and Chief Medical Officer of dgd Research, Inc., in San Antonio, Texas, presented this additional data from the clinical trial yesterday at a corporate symposium held in conjunction with the 68th Scientific Sessions of the American Diabetes Association being held in San Francisco, California, from June 6th to 10th.
“What is most encouraging about the data,” stated Dr. Schwartz, “is the observation that the TRIOLEX-treated subjects with the most impaired insulin resistance and higher levels of both insulin and fasting blood glucose had the largest improvement in these parameters. These data are intriguing because, in these subjects, the compound appeared to bring these parameters back to a normal range, which is important for safety concerns. To date there have been no reported incidence of hypoglycemia or any drug related serious adverse events. In addition, macrophage-induced inflammation in obese individuals is known to play an important role in causing insulin resistance. To see statistically significant reductions of MCP-1 in the serum and of IL-6 in cells of subjects treated with TRIOLEX versus subjects treated with placebo suggests the compound may be working through a novel pathway. The data demonstrating improvement in insulin sensitivity and glucose tolerance bode well for the potential of seeing a reduction in the clinical endpoint hemoglobin A1-c (HbA1-c) in a Phase II trial with TRIOLEX in patients with type 2 diabetes.”
Summary of Data Presented
The 28-day double-blind placebo controlled clinical trial was designed to study the safety, tolerability, pharmacokinetics and potential activity of TRIOLEX at three dose levels when administered orally (5mg once daily, 5mg twice daily and 10mg twice daily) to obese insulin resistant subjects. Data presented yesterday were from 31 subjects who participated in the clinical trial. The Company reported no serious adverse events or systemic toxicity to date from TRIOLEX in all treated subjects, and all adverse events reported were mild and required no treatment. A total of 17 subjects were evaluated for improvement in insulin sensitivity as measured by a physiological index of glucose disposal (M-value) under euglycemic/hyperinsulinemic clamp conditions, a method widely used to assess whole body glucose metabolism and to test compounds for the treatment of type 2 diabetes.
The data presented showed that pre-diabetic, insulin resistant subjects treated with TRIOLEX exhibited a statistically significant increase in the “M” value (p < 0.018), indicating that they became more sensitive or responsive to insulin. The magnitude of the effect seen with TRIOLEX was a 32.8% increase. This compares favorably to a meta-analysis of the effect of the glitazones in 23 studies of type 2 diabetics with a 34% increase in M value. The effect of TRIOLEX on M value was found to be linearly correlated with the magnitude of insulin resistance at baseline, before treatment (p = 0.015). Although these subjects are not considered hyperglycemic or diabetic, their fasting plasma glucose levels are nevertheless above the normal range (>100 mg/dL). Treatment with TRIOLEX was associated with a reduction in both fasting blood glucose and insulin, restoring these to normal levels without causing hypoglycemia. As in the case of the improved insulin sensitivity, these effects exhibited a highly significant linear correlation with respect to their initial blood glucose (p = 0.002) and insulin levels (p < 0.001) at baseline. In a similar fashion, a triglyceride lowering effect was observed, which correlated linearly with the degree of triglyceride elevation at baseline, before treatment began (p = 0.037). These observations suggest that the potential therapeutic benefit of TRIOLEX to abrogate insulin resistance occurs as a function of the magnitude of dysregulation of glucose homeostasis, as reflected by the extent of fasting hyperglycemia and hyperinsulinemia.
In addition to these findings, treatment with TRIOLEX at the highest dose caused a significant reduction by day 14 in serum levels of the chemokine MCP-1 (p = 0.035). MCP-1 is one of the major effectors of inflammation that mediates excessive infiltration of macrophages in adipose tissue and other insulin-sensitive tissues in obese subjects, leading to insulin resistance. It has now been demonstrated that many of these inflammatory molecules not only participate in a feed-forward cycle of “low grade” chronic inflammation, but they directly interfere with insulin signaling during obesity, thereby providing an explanation for the involvement of inflammation in insulin resistance and type 2 diabetes. Moreover, peripheral blood mononuclear cells obtained from patients treated with TRIOLEX at the highest dose exhibited markedly diminished responses by day 14 (p = 0.024) to a pro-inflammatory stimulus that normally induces a high level of IL-6 secretion, which is clearly conserved in patients treated with placebo in the same trial. Taken together, these observations suggest that the anti-inflammatory properties of TRIOLEX translate into improved insulin sensitivity in humans, thus ameliorating insulin resistance. The Company is now initiating a follow-on Phase II clinical trial to demonstrate efficacy in long-term glycemic control in type 2 diabetic patients by assessment of HbA1-c levels, an approvable end-point for diabetes.
Additional Symposium Highlights
In addition to the data presented by Dr. Schwartz at the symposium, Giovanni Solinas, Ph.D., Laboratory of Metabolic Stress Biology, Division of Physiology, Dept. of Medicine, University of Fribourg, Switzerland, highlighted the role of obesity-induced inflammation in causing insulin resistance. Dr. Solinas was the lead author of several publications linking obesity-induced inflammation to insulin resistance. Along with his own work, Dr. Solinas’ presentation included the work of several leading academic researchers who have reported that the chronic stimulation of the inflammatory kinases JNK and IKK can impair insulin signaling by inhibiting the biological function of IRS-1, a protein that acts as a major mediator of insulin action in target cells. This inflammatory pathway that leads to insulin resistance is well characterized in the scientific literature. In addition, activation of NF-kappaB due to inflammatory mediators or oxidative stress leads to a feed forward cycle of increased production of inflammatory cytokines such as MCP-1, TNF-alpha, IL-6 and IL-1beta.
William Cefalu, M.D., Professor and Chief, Division of Nutrition and Chronic Diseases, Pennington Biomedical Research Center, Louisiana State University System, highlighted the need for novel insulin sensitizers. He reviewed the current class of insulin sensitizers, known as PPAR-gamma agonists, and their efficacy and safety profile to date. He then described the potential mechanism of action of TRIOLEX and the differences between the glitazone class of insulin sensitizers and TRIOLEX. He pointed out that TRIOLEX acts independently of the PPAR-gamma pathway and thereby may avoid the side effects associated with the current glitazone class of insulin sensitizing agents, such as Avandia® and Actos®, which work through the PPAR-gamma pathway. Side effects reported to date with the glitazone class of drugs include weight gain, edema and increased cardiovascular events. To date, experiments in vitro have shown no evidence that TRIOLEX directly binds and/or transactivates the PPAR-gamma receptor. Unlike the glitazones, TRIOLEX does not cause body weight gain when administered to mice or rats. These and other observations are consistent with the Company’s finding that TRIOLEX works through a pathway independent of the PPAR-gamma receptor. TRIOLEX is a pharmaceutically optimized version of one of the body’s natural occurring ligands whose key function may be to restore immunological and metabolic homeostasis.
Richard Hollis, Chairman and CEO of Hollis-Eden, added, “We are honored to hold this symposium to assist the field of diabetes by advancing awareness of the latest research further establishing the role of inflammation as a culprit in insulin resistance. Furthermore, we are excited to share our clinical data supporting the potential role of our drug candidate TRIOLEX in addressing inflammation as an underlying cause of type 2 diabetes. While the primary focus of the study was safety and blood levels of TRIOLEX, by designing the study as we did, we were also able to show statistically significant signs of efficacy in improving insulin sensitivity, lowering fasting blood glucose levels, and lowering triglycerides, which is very exciting considering the limited treatment duration of only 28 days. These data, coupled with a significant reduction in levels of the inflammatory mediators MCP-1 and IL-6, further support our anti-inflammatory approach to improving insulin sensitivity and demonstrate the potential of TRIOLEX as an innovative, novel therapy for type-2 diabetes. Based on the consistently positive findings in our preclinical models of metabolic and inflammatory disorders, and our initial data in human clinical trials, we are now focused on accelerating our TRIOLEX development programs in type-2 diabetes, rheumatoid arthritis and inflammatory bowel disease (ulcerative colitis). Assuming successful clinical development and marketing approval by the FDA, we believe TRIOLEX represents a potential breakthrough therapy for metabolic disorders and inflammatory diseases that could be a first-in-line therapy with distinct competitive advantages in the marketplace relative to currently available treatments.”
Type 2 Diabetes Market
There are approximately 20 million Americans and over 160 million people worldwide with type 2 diabetes. As a result of an aging population and a rise in obesity rates, a common risk factor in this disease, the prevalence of type 2 diabetes is increasing rapidly. Included among the therapeutic approaches to type 2 diabetes are drugs designed to increase insulin production by the pancreas, drugs to reduce glucose production by the liver, and drugs to increase the body’s sensitivity to insulin, thereby improving glucose disposal by the blood stream. The global annual sales of oral anti-diabetic drugs exceed $11 billion annually. Of these insulin sensitizers, Avandia and Actos represent the largest class of oral anti-diabetic agents, currently garnering over $5 billion in worldwide sales annually. However, patient control of glucose levels remains a large unmet medical need as 64% of this patient population fails to achieve optimal glucose levels. Furthermore, now that it is increasingly understood that inflammation is at the root cause of insulin resistance, there is a need to address inflammation in type-2 diabetes.
MYECHECK INCORPORATED (OTCBB: MYEC)
"Up 14.79% in morning trading"
MyECheck, Inc., an early stage company, operates in the payment processing industry. It offers various solutions, such as real-time check authorization, payment guarantee, check image creation, and clearing and online reporting. The company's services include Remotely Created Check (RCC) Service, a payment engine that enables Internet merchants and other companies to accept payments online or over a telephone; and Check Authorization Service, which enables merchants to verify consumer provided data, check the status of the customer's bank account, provide evidence that the consumer has authorized the check, and predict the likelihood of a check being returned unpaid. Its services also include remote deposit capture and remittance processing solutions that enable companies to scan paper checks at the brick and mortar point of sale or back office, and remit check images for processing; merchant reporting services, including transaction history, and fees and settlement statements reports; and check guarantee services. In addition, the company offers services to support its RCC service, including fraud loss prevention services; and check remittance processing and remote deposit capture services for brick and mortar companies, such as banks and retailers. It provides electronic check image services to merchants, payment services providers, banks, and other businesses. The company was founded in 2004 and is based in El Dorado Hills, California.
June 9 -
MyECheck Inc. Announces Over 100% Growth in Revenues in First Two Months of Second Quarter 2008
Electronic Transaction Processor Also Posts April to May Revenue Growth at Over 60%
MyECheck Inc. (OTCBB: MYEC), an electronic transaction processor and provider of alternative payment solutions, announced that, in the first two months of the second quarter of 2008, unaudited revenues have exceeded the first quarter of 2008 by over 100%.
Furthermore, the company's unaudited revenues have increased by over 60% for the period May 2008 compared to April 2008.
The company noted that while there has been an economic downturn of late, the numbers would seem to point to a turn-around when it comes to online retailing. According to a recent report by eMarketer, "although consumers are reacting to the economic downturn by spending less, this will create more of a hardship for retail stores than for online retail outlets."
eMarketer estimates that US retail e-commerce sales (excluding travel) will reach $146 billion in 2008, up 14.3% over 2007.
And, according to Barrington Research, the 16-Stock group of electronic-transaction processors recorded its second consecutive month of positive price performance with a mean return of 4.47%. Twelve of the 16 stocks registered positive returns for the month, ranging from 2.8% for Western Union to 18.9% for Cardtronics. Besides Cardtronics, leading price performers for the month included Heartland Payments at 17.9%, Global Cash at 15.7% and Fidelity National 11.7%. The mean group return of 4.47% in May was greater than both the S&P 500 Index and the Dow Jones Industrial Average at 1% and minus-1.4%, respectively.
Ed Starrs, CEO of MyECheck, commented, "Our growth in this period is unprecedented for the company, and we expect that we will continue to increase our revenues as more of our customers are added."
The company notes that the numbers contained in this release are unaudited, and are made in good faith and based on all the financial information available to the company today.
MyECheck also wishes to caution readers that any forward looking statements are just beliefs or predictions, and that actual results might differ materially from those projected in any or all of the forward-looking statements. Further, past financial business, operations and stock performance are not necessarily indicative of the company's future performance.